Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
ImmuCell Corporation
ICCCCurrent price
3.6 USD
+0.002 USD (+0.06%)
Last closed
3.71 USD
Company
immucell.com
ISIN
US4525253062
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
28 434 082 USD
Yield for 12 month
-31.95 %
1Y
3Y
5Y
10Y
15Y
ICCC
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. The company operates through two segments, Scours and Mastitis. It offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, it is developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine. Address: 56 Evergreen Drive, Portland, ME, United States, 04103
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
14 USDP/E ratio
–Dividend Yield
–Current Year
+17 471 669 USD
Last Year
+18 568 000 USD
Current Quarter
+5 472 890 USD
Last Quarter
+7 257 577 USD
Current Year
+3 869 284 USD
Last Year
+7 649 000 USD
Current Quarter
+1 230 486 USD
Last Quarter
+2 295 359 USD
Key Figures ICCC
1 year
3 years
5 years
10 years
EBITDA
-633 697 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-4.87 %
PEG Ratio
–
Return On Equity TTM
-16.1 %
Wall Street Target Price
14 USD
Revenue TTM
23 222 928 USD
Book Value
2.99 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
54.9 %
Dividend Yield
–
Gross Profit TTM
7 648 779 000 USD
Earnings per share
-0.52 USD
Diluted Eps TTM
-0.52 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
-63.4 %
Profit Margin
-17.44 %
Dividend Analytics ICCC
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ICCC
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:100
Payout Ratio
–
Last Split Date
25.07.1990
Dividend Date
–
Stock Valuation ICCC
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
1.8493
Price Sales TTM
1.2244
Enterprise Value EBITDA
-21.1926
Price Book MRQ
1.2123
Financials ICCC
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ICCC
For 52 weeks
3.5 USD
5.64 USD
50 Day MA
3.93 USD
Shares Short Prior Month
2 472
200 Day MA
4.66 USD
Short Ratio
0.44
Shares Short
18 622
Short Percent
0.29 %
BeatStart